Literature DB >> 10626799

Sensitivity to polyamine-induced growth arrest correlates with antizyme induction in prostate carcinoma cells.

C Koike1, D T Chao, B R Zetter.   

Abstract

High local polyamine concentrations may suppress cell growth of primary prostatic carcinomas. When cell growth assays were conducted in defined serum-free medium, spermine inhibited the growth of poorly metastatic rat prostate carcinoma cells, causing cell cycle arrest in the G1 phase. In contrast, highly metastatic prostate carcinoma cells were resistant to the growth inhibitory activity of spermine. Ornithine decarboxylase antizyme levels, measured by Western blotting, were elevated 1-2 h after spermine treatment of spermine-sensitive cells but not spermine-resistant cells. Spermine uptake was similar in both the sensitive and resistant cell lines. These results suggest that failure to induce antizyme correlates with spermine resistance in prostate carcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626799

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Antizyme affects cell proliferation and viability solely through regulating cellular polyamines.

Authors:  Zippi Bercovich; Zohar Snapir; Alona Keren-Paz; Chaim Kahana
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

2.  Antizyme induction by polyamine analogues as a factor of cell growth inhibition.

Authors:  John L A Mitchell; Aviva Leyser; Michelle S Holtorff; Jill S Bates; Benjamin Frydman; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

3.  The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification.

Authors:  Dirk Geerts; Jan Koster; David Albert; Dana-Lynn T Koomoa; David J Feith; Anthony E Pegg; Richard Volckmann; Huib Caron; Rogier Versteeg; André S Bachmann
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

4.  Antizyme restrains centrosome amplification by regulating the accumulation of Mps1 at centrosomes.

Authors:  Christopher Kasbek; Ching-Hui Yang; Harold A Fisk
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

5.  Ornithine decarboxylase antizyme induces hypomethylation of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2) in human oral cancer cell line.

Authors:  Daisuke Yamamoto; Kaori Shima; Kou Matsuo; Takashi Nishioka; Chang Yan Chen; Guo-Fu Hu; Akira Sasaki; Takanori Tsuji
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

6.  Antizyme induction mediates feedback limitation of the incorporation of specific polyamine analogues in tissue culture.

Authors:  John L A Mitchell; Carrie L Simkus; Thynn K Thane; Phil Tokarz; Michelle M Bonar; Benjamin Frydman; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

7.  Regulation of all members of the antizyme family by antizyme inhibitor.

Authors:  Ursula Mangold; Ekkehard Leberer
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

8.  Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients.

Authors:  Yi-Shing Lisa Cheng; Lee Jordan; Terry Rees; Huey-Shys Chen; Lance Oxford; Ole Brinkmann; David Wong
Journal:  Clin Oral Investig       Date:  2013-07-28       Impact factor: 3.573

9.  Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers.

Authors:  Y-S L Cheng; L Jordan; H-S Chen; D Kang; L Oxford; J Plemons; H Parks; T Rees
Journal:  J Periodontal Res       Date:  2016-08-23       Impact factor: 4.419

Review 10.  Ribosomal frameshifting in decoding antizyme mRNAs from yeast and protists to humans: close to 300 cases reveal remarkable diversity despite underlying conservation.

Authors:  Ivaylo P Ivanov; John F Atkins
Journal:  Nucleic Acids Res       Date:  2007-03-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.